ALLR (Allarity Therapeutics) Institutional Ownership: 7.53% (As of Jul. 11, 2026)


ALLR Allarity Therapeutics Inc ALLR
26 GF Score
Price $1.17
! 2 Warning Signs
View Full Analysis

What is Allarity Therapeutics Institutional Ownership?

Allarity Therapeutics ALLR -2.91% 26 Institutional Ownership is 7.53% as of Jul. 11, 2026. GuruFocus rates ALLR with a GF Score™ of 26/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Allarity Therapeutics's institutional ownership is 7.53%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Allarity Therapeutics's Insider Ownership is 8.47%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Allarity Therapeutics's Float Percentage Of Total Shares Outstanding is 99.85%.

Allarity Therapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Allarity Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allarity Therapeutics Institutional Ownership Chart

Allarity Therapeutics Historical Data

The historical data trend for Allarity Therapeutics can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-05-31 2026-06-30
Institutional Ownership 0.80 3.43 3.43 3.43 1.29 1.30 1.30 1.82 1.81 1.66
ALLR
26GF Score
Allarity Therapeutics Inc ALLR
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Allarity Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 7.53% mean?
Allarity Therapeutics (ALLR) has a Institutional Ownership of 7.53% as of Jul. 11, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Allarity Therapeutics and its competitors.
Is Allarity Therapeutics' Institutional Ownership too high?
Allarity Therapeutics' current Institutional Ownership is 7.53%. Overall, Allarity Therapeutics has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Allarity Therapeutics' Institutional Ownership compare to NCEL and LPCN?
Allarity Therapeutics' Institutional Ownership of 7.53% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Allarity Therapeutics and its competitors. Allarity Therapeutics's current Institutional Ownership is 7.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allarity Therapeutics stock overvalued right now?
Allarity Therapeutics (ALLR) has a current Institutional Ownership of 7.53%. The current Institutional Ownership is 7.53%. Allarity Therapeutics' overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Allarity Therapeutics (ALLR), the current Institutional Ownership is 7.53% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Allarity Therapeutics Business Description

Address 123 East Tarpon Avenue, Tarpon Springs, FL, USA, 34689
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.
26GF Score

Get the complete analysis for ALLR

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.17
Price